Mirae Asset Global Etfs Holdings Ltd. Nuvation Bio Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 136,697 shares of NUVB stock, worth $507,145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
136,697
Previous 108,547
25.93%
Holding current value
$507,145
Previous $191,000
39.27%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NUVB
# of Institutions
193Shares Held
168MCall Options Held
2.31MPut Options Held
221K-
Decheng Capital LLC Menlo Park, CA26MShares$96.3 Million12.78% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$60.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.9MShares$59 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA11MShares$41 Million46.36% of portfolio
-
Laurion Capital Management LP New York, NY10.2MShares$38 Million0.37% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $806M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...